BRIEF published on 08/05/2024 at 07:05, 1 year 4 months ago Relief Therapeutics obtient jusqu'à 11 millions de dollars grâce aux ventes de redevances Développement Clinique Financement Non Dilutif Approbation De La FDA Thérapeutique De Soulagement Ventes De Redevances
PRESS RELEASE published on 08/05/2024 at 07:00, 1 year 4 months ago Relief Therapeutics Secures up to $11 Million from Royalty Sales Relief Therapeutics secures $11 million from royalty sales for RLF-TD011 clinical development and pipeline advancement. Funding from SWK Holdings Corporation to support rare disease treatment options SWK Holdings Corporation Clinical Development Relief Therapeutics Rare Diseases Royalty Sales
BRIEF published on 06/27/2024 at 12:50, 1 year 5 months ago Relief Therapeutics Holding SA publie les résultats de son assemblée générale annuelle Actionnaires Conseil D'administration États Financiers Résultats De L'AGA Thérapeutique De Soulagement
BRIEF published on 06/27/2024 at 12:50, 1 year 5 months ago Relief Therapeutics Holding SA Reports Results of Annual General Meeting Board Of Directors Shareholders Financial Statements Relief Therapeutics AGM Results
PRESS RELEASE published on 06/27/2024 at 12:45, 1 year 5 months ago RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting RELIEF THERAPEUTICS Holding SA announces the results of its Annual General Meeting of Shareholders in Geneva. Details on approved resolutions and election outcomes Annual General Meeting Shareholders Resolutions RELIEF THERAPEUTICS Holding SA Geneva
BRIEF published on 06/03/2024 at 07:05, 1 year 6 months ago Relief Therapeutics Announces Executive Changes Board Of Directors Executive Changes Biopharmaceutical Relief Therapeutics Senior Management
BRIEF published on 06/03/2024 at 07:05, 1 year 6 months ago Relief Therapeutics annonce des changements à la direction Conseil D'administration Biopharmaceutique Changements De Direction Thérapeutique De Soulagement La Haute Direction
PRESS RELEASE published on 06/03/2024 at 07:00, 1 year 6 months ago Relief Therapeutics Announces Executive Changes Relief Therapeutics announces executive changes as interim CEO Michelle Lock completes her mandate and transitions out, along with other key executives. Board to review management for optimal results Executive Changes Biopharmaceutical Relief Therapeutics Rare Diseases Management Review
BRIEF published on 05/30/2024 at 07:05, 1 year 6 months ago Relief Therapeutics annonce l'avis de convocation à l'assemblée générale annuelle des actionnaires Biopharmaceutique AGA 2024 Thérapeutique De Soulagement Rencontre D'actionnaires Genève
BRIEF published on 05/30/2024 at 07:05, 1 year 6 months ago Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders Biopharmaceutical Relief Therapeutics AGM 2024 Shareholders Meeting Geneva
Published on 12/05/2025 at 02:35, 6 hours 44 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 19 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 14 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 19 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:05, 13 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 34 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 34 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 36 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 15 hours 4 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 15 hours 19 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
